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The Human Phenotype Ontology: A Tool for Annotating
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and Stefan Mundlos1,2,4
There are many thousands of hereditary diseases in humans, each of which has a speciﬁc combination of phenotypic features, but
computational analysis of phenotypic data has been hampered by lack of adequate computational data structures. Therefore, we
have developed a Human Phenotype Ontology (HPO) with over 8000 terms representing individual phenotypic anomalies and have
annotated all clinical entries in Online Mendelian Inheritance in Man with the terms of the HPO. We show that the HPO is able to
capture phenotypic similarities between diseases in a useful and highly signiﬁcant fashion.Analysis of the phenotypic correlates of gene mutations
has long been an essential method for discovering biolog-
ical functions of genes, and more recently, computational
analysis of mouse phenotypes related to gene mutations
has become possible with tools such as the Mammalian
Phenotype Ontology.1,2 Phenotypic analysis has played
a central role in the mapping of disease genes and many
other ﬁelds, and humans are particularly good at recogniz-
ing human phenotypic traits and anomalies. However,
there are a number of unresolved issues surrounding
the computational description and analysis of human
phenotypes.
It seems intuitively clear that certain hereditary disorders
are phenotypically similar to one another because of
shared phenotypic features. For instance, one might say
that Marfan syndrome (MIM 154700) and congenital
contractural arachnodactyly (MIM 121050) are similar
because they share a range of skeletal abnormalities, and
in fact the genes mutated in these syndromes, FBN1 and
FBN2, belong to the same gene family and share a number
of functional similarities.3 The observation that many ge-
netic conditions show overlapping features led to the con-
cept of disease families.4,5 Phenotypic similarities within
disease families may be related to dysfunction of a regula-
tory network, such as a signaling pathway or a biochemical
module, as has been demonstrated for Noonan syndrome
(MIM 163950) and related disorders.6 Thus, phenotypic
analysis is of great importance for our understanding of
the physiology and pathophysiology of cellular networks
because it can offer clues about groups of genes that
together make up pathways or modules, in which dysfunc-
tion can lead to similar phenotypic consequences. A num-
ber of recent works have suggested the enormous potential
of correlating phenotype to features of genetic or cellular
networks on a genome-wide scale.7–9
The great majority of human Mendelian syndromes
have been described in detail in the Online Mendelian
Inheritance in Man (OMIM) database,10 and hierarchical610 The American Journal of Human Genetics 83, 610–615, Novembsystems based on the clinical descriptions in OMIM have
been generated by text mining.11–13 However, computa-
tional analysis of the data contained in OMIM has so far
been hampered by the lack of a controlled vocabulary
including consistent annotations with well-deﬁned rela-
tionships to one another. For instance, the descriptions
‘‘generalized amyotrophy,’’ ‘‘generalized muscle atrophy,’’
‘‘muscular atrophy, generalized,’’ and ‘‘muscle atrophy,
generalized’’ are used to describe different diseases in
OMIM and might not be easily recognized as synonyms
with a purely computational approach. Also, although
the clinical-synopsis entries in OMIM are grouped accord-
ing to organ system, the hierarchical structure does not
itself reﬂect that (for instance) ‘‘Hypoplastic philtrum’’
and ‘‘Smooth philtrum’’ are more closely related to one
another than to ‘‘Hypoplastic nasal septum’’ (all three of
these descriptions are in the NOSE category of OMIM’s
clinical synopsis).
An ontology is a data model that represents concepts, at-
tributes, and relationships in the form of a directed acyclic
graph. The Gene Ontology (GO), especially, has proven to
be extremely useful for the exploratory analysis of microar-
ray and other forms of high-throughput data.14 A number
of considerations suggest that an ontological description of
human phenotypes has distinct advantages; this prompted
us to develop an ontology to describe human phenotypic
abnormalities.
The Human Phenotype Ontology (HPO) was con-
structed with the goal of covering all phenotypic abnor-
malities that are commonly encountered in human
monogenic diseases. To this end, the ‘‘omim.txt’’ ﬁle was
downloaded from the OMIM database.10 We developed
a suite of Java programs and Perl scripts to parse omim.txt
in order to extract the textual descriptions of each disease
as listed in the Clinical Synopsis section, which is ordered
in a hierarchical fashion. For instance, in the description of
Marfan syndrome, aortic root dilatation is listed under the
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Figure 1. The Human Phenotype Ontology
The HPO term Bilateral congenital hip dislocation and all paths to the root that emanate from this term are shown. Some of the annotated
disease entries from OMIM, as well as the total number of annotated diseases, are shown next to the terms. Note that because of the
true-path rule, a disease that is directly annotated to a specific term is also implicitly annotated to all ancestors of that term. For
instance, Ehlers Danlos syndrome type VII is directly annotated to Bilateral congenital hip dislocation and is thereby implicitly annotated
to Abnormality of the hips, Dislocations, and the other terms shown in the figure.then generated a list of these features, sorted according to
the frequency of occurrence. For instance, aortic root dilata-
tion is listed for a number of diseases other than Marfan
syndrome, including Ehlers-Danlos syndrome, type I
(MIM 130000). On the other hand, Medial rotation of the
medial malleolus is used only once (for Marfan syndrome)
in all of omim.txt.
The HPOwas then constructed with OBO-Edit15 in order
to deﬁne terms and the links between them on the basis of
the list of descriptions from omim.txt. For all descriptions
that occurred more than once in omim.txt, we created
a term in the HPO. One of the main difﬁculties in using
data from OMIM in computational analysis is that
OMIM does not use a controlled vocabulary, and it can
be difﬁcult to recognize synonyms by computational
means. Therefore, we manually curated each term, taking
advantage of domain knowledge in human genetics
(PNR, DH, SM) in order to merge synonyms into unique
HPO terms. For instance, the three OMIM descriptions
Carpal bone hypoplasia, Hypoplasia of carpal bones, and
Hypoplastic carpal bones were fused into the single termThe AmericaHP:0001498, Carpal bone hypoplasia. We additionally adap-
ted the Smith-Waterman algorithm16 to map additional
descriptions that were used only once in omim.txt as syn-
onyms or children of HPO terms. However, each mapping
proposed by this algorithm was examined by hand before
incorporation into the HPO. Domain knowledge was also
used to deﬁne more general terms, such as Aplasia/hypopla-
sia of the outer ear, to groupmore speciﬁc terms, as well as to
deﬁne links between individual terms.
Each term in the HPO describes a phenotypic abnormal-
ity, such as Atrial septum defect. Terms are related to parent
terms by ‘‘is a’’ relationships. The structure of the HPO,
which allows a term to havemultiple parent terms, enables
different aspects of phenotypic abnormalities to be ex-
plored (see Figure 1 for an example). The HPO itself does
not describe individual disease entities but, rather, the phe-
notypic abnormalities associated with them. The majority
of the HPO terms describe organ abnormalities, but sepa-
rate ontologies are provided for describing the mode of
inheritance and the onset and clinical course. We have
used the HPO terms to annotate all entries of OMIMn Journal of Human Genetics 83, 610–615, November 7, 2008 611
Figure 2. Applications of the HPO
(A) Visualization of the human phenome. Each of 727 diseases listed in OMIM for which a disorder class was defined is shown as a node in
the graph and is colored according to membership in a set of 21 predefined disorder classes, defined on the basis of the physiological
system.7 The organic layout algorithm of Cytoscape27 was used for showing the clustered structure of the phenotypic network. Connec-
tions between nodes are shown starting from a similarity score of 4.5, whereby the thickness of the connection reflects the degree of
phenotypic similarity. Abbreviations are as follows: CV, cardiovascular; derma, dermatological; endo, endocrinological; heme, hemato-
logical; immuno, immunological; metab, metabolic; neuro, neurological; ophth, ophthalmological.
(B) Analysis of randomized phenotypic networks. In order to estimate the probability that this result could be due to chance, we created
10,000 random networks in which edges were randomly rewired 2000 times.28 The mean network score of the random nets was 0.1825
0.0098. Thus, the actual score of 0.645 was 47.2 standard deviations above the mean random score.612 The American Journal of Human Genetics 83, 610–615, November 7, 2008
with a clinical-synopsis section. Clinical entities are anno-
tated to the most speciﬁc terms possible. The true-path
rule17 applies to the terms of the HPO. That is, if a disease
is annotated to the term Atrial septal defect, then all of the
ancestors of this term, such as Abnormality of the cardiac
septa, also apply. The structure of the HPO, therefore,
allows ﬂexible searches for disease entities according to
phenotypic abnormalities, with a broad or narrow focus.
Wewill now show that an ontological similaritymeasure
deﬁnes a useful and highly signiﬁcant phenotypic-similar-
ity metric among hereditary diseases listed in OMIM. In
the HPO, as in GO, terms that are closer to the root of
the ontology represent more general concepts than do
terms that are farther away from the root. (For instance,
in Figure 1, the term Abnormality of the joints is more gen-
eral than the term Congenital hip dislocation.) The informa-
tion content of each node in the HPO can be estimated
through its frequency among annotations of the entire
OMIM corpus. In our implementation, the information
content of a term is based on the frequency of annotations
to that term among the 4779 diseases in the OMIM data-
base that were annotated to terms of the HPO. Intuitively,
if two diseases are both annotated to a term with high
information content, such as Calciﬁc stippling, then the
degree of similarity calculated on the basis of this should
be higher than that calculated when the two diseases are
both annotated to a more general term, such as Abnormal-
ity of the musculoskeletal system, which has a lower informa-
tion content.
For each term t of the HPO, the information content is
quantiﬁed as the negative logarithm of its probability:
logp(t), in which the probability of a term is taken to be
its frequency among annotations to all 4779 annotated
diseases. If a disease is annotated to any term t in the
HPO, it must also be annotated to all the ancestors of
t. Therefore, the higher in the ontology a term is located,
the lesser its information content. Resnik18 introduced
a similarity measure for two terms in an ontology that is
based on their shared information content, which is given
by the information content in the set of their common-
ancestor nodes. In the case of HPO, a term might have
multiple parent terms, so that a pair of terms might have
more than one path of common ancestors. Denoting the
set of all common-ancestor terms of terms t1 and t2 as
A(t1, t2), we deﬁne the similarity between two terms, t1
and t2, as
simðt1,t2Þ ¼ max
a˛Aðt1,t2Þ
log pðaÞ, (1)The Americawhich deﬁnes the probability of the minimum common
ancestor of t1 and t2. Individual diseases are usually anno-
tated to multiple phenotypic features. In order to calculate
the similarity between two diseases, d1 and d2, we adapt
a method previously developed for estimating protein sim-
ilarity with GO,19 whereby each feature of d1 is matched
with the most similar feature of d2 and the average is taken
over all such pairs of features:
simðd1/d2Þ ¼ avg
"X
s˛d1
max
ted2
simðs,tÞ
#
: (2)
Because Equation (2) is not symmetric with respect to d1
and d2, the ﬁnal similarity metric is deﬁned as the mean of
Equation (2) taken in both orientations:
simðd1,d2Þ ¼ 1
2
3 simðd1/d2Þ þ 1
2
3 simðd2/d1Þ: (3)
This metric can now be used to deﬁne the similarity
between two diseases, each of which is annotated to
multiple terms of the HPO.
We used this measure to deﬁne similarity between the
diseases listed in the OMIM database. We analyzed 727
diseases belonging to one of 21 physiological-disorder
classes.7 Phenotypic relationships between these diseases
are shown by the linking of all pairs of diseases exceeding
a threshold similarity score (Figure 2A). Although gener-
ated independently of the disorder classes, the resulting
phenotypic network clearly displays clusters correspond-
ing to many of the 21 classes. It is also apparent that
some of the clusters show interconnections between one
another, which were not visible in the disease map based
only on shared disease genes.7 For instance, hematological
disorders are strongly connected to immunological disor-
ders, bone disorders are strongly connected to skeletal
disorders, and neurological, muscular, and psychiatric
disorders are multiply linked to one another. Also, diseases
that cluster together with diseases from a different physio-
logical class share important phenotypic similarities with
that class. For instance, all four diseases that are from the
metabolic class and are located in the muscle cluster (Eno-
lase-beta deﬁciency, MCardle disease, dimethylglycine
dehydrogenase deﬁciency, and elevated serum creatine
phosphokinase) show important muscular symptoms (Fig-
ure 2A). Analysis of randomized networks showed that the
observed correlation between network connections and
disease class is highly signiﬁcant (Figure 2B). Thus, this
phenotypic network, as deﬁned by the HPO, is made up(C) Searching the HPO. All 2116 diseases listed in OMIM with at least six HPO annotations were identified and included in the analysis. For
each disease, between 1 and 6 of the most specific terms to which the disease is annotated in the HPO were used for the search
(‘‘Annotated terms’’). The set of clinical features determined in this way was then used for querying the entire set of OMIM diseases
for the best match. The average rank of the original disease among the diseases identified by the search for different proportions of
removed terms is shown. In separate experiments, each of these terms was mapped to a parent term or 50% unrelated (‘‘noise’’) terms
were added (rounded up for odd numbers of terms; i.e., one noise term was added to searches with one term, two noise terms to searches
with three terms, and three noise terms to searches with five terms).n Journal of Human Genetics 83, 610–615, November 7, 2008 613
of dense clusters of shared phenotypic features that show
characteristic patterns of interconnections between
selected areas of the phenotypic continuum.
Next,we explored theutility ofusing theHPOinaclinical
setting. Combinations of features are often used inmedical
genetics in the search for a clinical diagnosis. This can be
a challenging undertaking, given the large number of
hereditary disorders and the range of partially overlapping
clinical features associated with them. Clinicians may be
able to describe clinical features in varying levels of detail.
Also, an individual patient with a hereditary disease might
not show all of the features that are potentially associated
with a disorder, or he or she may have additional features
unrelated to the disorder. Optimally, diagnostic algorithms
will allow searches at varying levels of detail, weigh speciﬁc
features more highly than general features, and not be
overly sensitive to the fact that individual features might
not be present in an individual patient. An ontological
approach, therefore, appears to be particularly appropriate
in this setting. To simulate this kind of search process, we
used the 2116 diseases in OMIM annotated to at least six
HPO terms to simulate a clinical-search process by selecting
only 1–6 of the terms associated with a given disease and
then searching in the original database for similar diseases.
Optimally, the search algorithm will assign the original
disease the highest rank or at least place it among the ﬁrst
fewdiseases. As canbe seen inFigure 2C, therewas excellent
performance, even when only two search terms were used,
with relatively small reductions in accuracy when 50% of
random noise terms were added to the search terms or
when each of the terms was mapped to a (less speciﬁc)
parent term. This suggests that the HPO is able to capture
phenotypic similarity at various levels of granularity and
that the calculation of similarity is not overly sensitive to
noise, completeness, or speciﬁcity of the set of phenotypic
terms used for the search.
Previous efforts at computational analysis of phenotypic
data in human hereditary disease have involved various
strategies for automated text mining of OMIM. A number
of works have used MeSH terms or Uniﬁed Medical
Language System (UMLS) concepts tomapphenotypic con-
cepts from medline or OMIM.13,20–22 Most of these works
used the text-mined concepts to create feature vectors in
order todescribediseases. That is, a feature vector for a given
disease contains one entry for each concept, set to 1 if the
concept is found in the disease and to 0 otherwise. Similar-
ity is often measured by some variation of the normalized
cosine angle between normalized feature vector pairs.22
Although these works were successful, we contend that
amanually curated ontological approach to computational
phenotype analysis offers a number of advantages. One dif-
ﬁculty with text-mining approaches is that the MeSH and
UMLS indexing terms are not speciﬁcally designed for the
needs of describing human hereditary diseases and their
phenotypes. For instance, only 34% of 1700 diseases with
a speciﬁc phenotype associated with a speciﬁc gene in
OMIM could be speciﬁcally mapped to concepts in the614 The American Journal of Human Genetics 83, 610–615, NovembUMLS.23 One advantage of the HPO is that the terms and
structure of the ontology are based on medical knowledge
rather than on text-mining systems. The HPO will be
reﬁned and extended in the future. An ontology as a data
structure has several distinct advantages over other kinds
of data structure that have been used for phenotypic analy-
sis. One of the main reasons for the success of GO is the
greater ﬂexibility and descriptive power of ontologies
compared to hierarchical systems and feature vectors,14
including the ability to relate concepts (terms) to multiple
parents and to allow descriptions and queries at different
levelsofgranularityandcompleteness.Additionally, anum-
ber of computational algorithms have been developed for
ontological analysis after the success of GO (e.g., 19,24,25)
and can now be applied to human phenotype data.
The value of data is greatly increased as sources of data
are enabled to be integrated with one another. We have de-
signed the HPO using the widely used OBO format.26 This
ﬁle, together with a ﬂat ﬁle with annotations of 4779 dis-
eases listed in OMIM to the terms of the HPO, is freely
available for download from the HPO web site, which
also describes the background and goals of the project.
The HPO is participating in the OBO Foundry project,26
and the ﬁles are available for download there as well. We
anticipate that the HPO will continue to evolve over
many years and are currently recruiting collaborators to
reﬁne speciﬁc areas of the HPO, to improve annotations
to disorders listed in OMIM, and to extend the annotations
to other hereditary disorders, such as microdeletion syn-
dromes and chromosomal aberrations. We plan to include
additional information, including frequency and severity
of features, in the annotation ﬁles. It is hoped that the
HPO will provide a basis for computational biomedical
research involving human phenotype analysis, allowing
the human phenome to be related to the molecular patho-
physiology of the cell by directly linking the human
phenome to sources of data such as protein-protein inter-
actions, metabolic and signal-transduction pathways, and
gene coexpression. Additionally, we anticipate that the
HPO will provide a uniﬁed basis for clinical research in
medical genetics by providing a standardized vocabulary
for the description of phenotypes.
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